The SMartha Lab is currently investigating the relationship between metabolomic/lipidomic markers, development of symptoms and outcomes in persons diagnosed with acute ischemic stroke (AIS). AIS is the leading cause of severe long-term disability and affects more than 800,000 Americans annually. Half of AIS survivors exhibit fatigue and depressive symptoms, cognitive deficits, and poorer functional and health-related quality of life (HRQOL) outcomes.
This work is funded by NIH/NINR K23NR016864, STTI/WIN Research Grant (#17775), and AMWF Research Grant, AANN.
Karen's quote Heading link
I had the stroke. That stroke didn’t have ME!Stroke Study Participant|
Winter's quote Heading link
Some of the questions you ask me are ones I think about. Other questions are things I haven’t thought about and need to! You make me aware of important stroke issues.